Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle Marcoux

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Journal of Cutaneous Medicine and Surgery|November 7, 2019
Approach to the Assessment and Management of Pediatric Patients With Atopic Dermatitis: A Consensus Document. Section IV: Consensus Statements on the Assessment and Management of Pediatric Atopic DermatitisPerla Lansang, Irene Lara-Corrales, James N Bergman, et al.
Pediatric Dermatology|February 15, 2013
Therapeutic patient education in atopic dermatitis: worldwide experiencesJean-Francois Stalder, Claire Bernier, Alan Ball, et al.
Journal of Cutaneous Medicine and Surgery|May 22, 2016
Canadian Clinical Practice Guidelines for RosaceaYuka Asai, Jerry Tan, Akerke Baibergenova, et al.
Journal of Cutaneous Medicine and Surgery|November 9, 2016
Definition of Moderate to Severe Hidradenitis Suppurativa: A Position Paper by the Canadian Hidradenitis Suppurativa Foundation (CHSF)Afsaneh Alavi, David N Adam, Ra'ed Alhusayen, et al.
Journal of the American Academy of Dermatology|January 26, 2022
Disease characteristics, comorbidities, treatment patterns and quality of life impact in children <12 years old with atopic dermatitis: Interim results from the PEDISTAD Real-World RegistryAmy S Paller, Emma Guttman-Yassky, Marie L A Schuttelaar, et al.
The Lancet. Child & Adolescent Health|June 3, 2026
Delgocitinib cream for adolescents with moderate to severe chronic hand eczema (DELTA TEEN): a multicentre, double-blind, phase 3 randomised controlled trialSonja Molin, Eulalia Baselga, Francisco J Navarro-Triviño, et al.
Frontiers in Medicine|September 20, 2021
Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic DermatitisMichelle Le, Melissa Berman-Rosa, Feras M Ghazawi, et al.
American Journal of Clinical Dermatology|September 19, 2025
Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD RegistryAmy S Paller, Danielle Marcoux, Michele Ramien, et al.
Journal of the American Academy of Dermatology|October 10, 2024
Real-world treatment outcomes of systemic treatments for moderate-to-severe atopic dermatitis in children aged less than 12 years: 2-year results from PEDIatric STudy in Atopic DermatitisAmy S Paller, Marjolein de Bruin-Weller, Danielle Marcoux, et al.
Dermatology and Therapy|April 17, 2026
Summary of Research: Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD RegistryAmy S Paller, Danielle Marcoux, Michele Ramien, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Journal of Cutaneous Medicine and Surgery|November 7, 2019
Approach to the Assessment and Management of Pediatric Patients With Atopic Dermatitis: A Consensus Document. Section IV: Consensus Statements on the Assessment and Management of Pediatric Atopic DermatitisPerla Lansang, Irene Lara-Corrales, James N Bergman, et al.
Pediatric Dermatology|February 15, 2013
Therapeutic patient education in atopic dermatitis: worldwide experiencesJean-Francois Stalder, Claire Bernier, Alan Ball, et al.
Journal of Cutaneous Medicine and Surgery|May 22, 2016
Canadian Clinical Practice Guidelines for RosaceaYuka Asai, Jerry Tan, Akerke Baibergenova, et al.
Journal of Cutaneous Medicine and Surgery|November 9, 2016
Definition of Moderate to Severe Hidradenitis Suppurativa: A Position Paper by the Canadian Hidradenitis Suppurativa Foundation (CHSF)Afsaneh Alavi, David N Adam, Ra'ed Alhusayen, et al.
Journal of the American Academy of Dermatology|January 26, 2022
Disease characteristics, comorbidities, treatment patterns and quality of life impact in children <12 years old with atopic dermatitis: Interim results from the PEDISTAD Real-World RegistryAmy S Paller, Emma Guttman-Yassky, Marie L A Schuttelaar, et al.
The Lancet. Child & Adolescent Health|June 3, 2026
Delgocitinib cream for adolescents with moderate to severe chronic hand eczema (DELTA TEEN): a multicentre, double-blind, phase 3 randomised controlled trialSonja Molin, Eulalia Baselga, Francisco J Navarro-Triviño, et al.
Frontiers in Medicine|September 20, 2021
Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic DermatitisMichelle Le, Melissa Berman-Rosa, Feras M Ghazawi, et al.
American Journal of Clinical Dermatology|September 19, 2025
Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD RegistryAmy S Paller, Danielle Marcoux, Michele Ramien, et al.
Journal of the American Academy of Dermatology|October 10, 2024
Real-world treatment outcomes of systemic treatments for moderate-to-severe atopic dermatitis in children aged less than 12 years: 2-year results from PEDIatric STudy in Atopic DermatitisAmy S Paller, Marjolein de Bruin-Weller, Danielle Marcoux, et al.
Dermatology and Therapy|April 17, 2026
Summary of Research: Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD RegistryAmy S Paller, Danielle Marcoux, Michele Ramien, et al.
Pageof 6